Strategy for the treatment of fungal infections in critically ill surgical patients

Japanese Journal of Medical Mycology

Volumn 45, Issue 4, 2004, Pages 217-221

  Takesue, Yoshio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Fluconazole; Non albicans Candida; Postoperative infection; Pre emptive therapy

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA GLUCAN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; STEROID; VORICONAZOLE;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CANDIDA; CANDIDIASIS; CRITICAL ILLNESS; EMPIRIC THERAPY; HEMODIALYSIS; HUMAN; INTENSIVE CARE UNIT; MYCOSIS; NONHUMAN; POSTOPERATIVE INFECTION; PREEMPTIVE THERAPY; REVIEW; RISK FACTOR; SEPSIS; STEROID THERAPY; SURGICAL PATIENT; TARGETED THERAPY;

CANDIDA; FUNGI;

EID: 10044250855     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.45.217     Document Type: Review

References (24)

1. Fridkin S, Jarvis WR: Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9: 499-511, 1996.
2. Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149: 2349-2353, 1989.
3. Solomkin JS, Flohr AM, Simmons RC, et al.: Indication for therapy for fungemia in postoperative patients. Arch Surg 117: 1272-1275, 1982.
4. Pfaller AM, Jones RN, Messer SA, et al.: National surneillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 30: 121-129, 1998.
5. Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751-758, 1994.
6. British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20: 522-528, 1994.
7. Burchard KW, Minor LB, Slotman GJ, et al.: Fungal sepsis in surgical patients. Arch Surg 118: 217-221, 1983.
8. Phillips P, Dowd A, Jewesson P, et al.: Nonvalue of antigen detection immunoassays for diagnosis of candidemia. J Clin Microbiol 28: 2320-2326, 1990.
9. Obayashi T, Yoshida M, Mori T, et al.: Plasma (1,3) β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345: 17-20, 1995.
10. Eggiman P, Francioli P, Bille J, et al.: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27: 1066-1072, 1999.
11. Pelz RK, Hendix CW, Swoboda SM, et al.: Double-blinded placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233: 542-548, 2001.
12. Patterson TF: Role of newer azoles in surgical patients. J Chemother 11: 504-512, 1999.
13. Wingard JR, Merz WG, Rinaldi MG, et al.: Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 37: 1847-1849, 1993.
14. Abi-Said D, Anaissie E, Uzun O, et al.: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24: 1122-1128, 1997.
15. Gumbo T, Isada CM, Hall G, et al.: Candida glabrata fungemia Clinical features of 139 patients. Medicine 78: 220-227, 1999.
16. Nguyen MH, Peacock JE, Morris AJ, et al.: The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100: 617-623, 1996.
17. Rex JH, Walsh TJ, Sobel JD, et al.: Practice guideline for the treatment of candidiasis. Clin Infect Dis 30: 662-678, 2000.
18. Wong-Beringer A, Jacobs RA, Guglielmo BJ: Lipid formation of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 27: 603-618, 1998.
19. Ruhnke M, Schmidt-Westhausaen A, Trautmann M: In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection. Antimicrob Agent Chemother 41; 575-577, 1997.
20. Rex JH, Bennett JE, Sugar AM, et al.: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patient without neutropenia. N Engl J Med 331: 1325-1330, 1994.
21. Edwards JE Jr: International Conference for the development of a consensus on the management and prevention of severe candidal infections. CID 25: 43-59, 1997.
22. Luiten EJT, Hop WCJ, Lange JF, et al.: Controlled clinical trial selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222: 57-65, 1999.